top of page

Ductal Carcinoma In Situ: What You Need to Know

What is ductal carcinoma in situ? 

When abnormal cells are discovered in the lining of a breast duct but haven't gone elsewhere, the condition is known as ductal carcinoma in situ (DCIS). It's usually detected through mammograms and is considered an early stage of breast cancer. While not invasive, if left untreated, DCIS can sometimes progress to invasive breast cancer. Treatment options frequently involve surgery, such as a lumpectomy or mastectomy, radiation therapy, or hormonal therapy, based on the specifications of each patient. Regular monitoring and appropriate treatment are crucial to prevent the progression of invasive cancer.

 

What are the symptoms of ductal carcinoma in situ?

 

1. Usually Asymptomatic: DCIS often does not present any noticeable symptoms. It's commonly detected through routine mammograms or diagnostic procedures for unrelated breast issues.

2. Breast Changes: In some cases, women may notice changes in their breasts, such as a lump, thickening, or discharge from the nipple. These changes, however, can also be caused by other non-cancerous conditions.

3. Pain or Discomfort: Rarely, individuals might experience pain or discomfort in the affected breast, but this is not a typical symptom and could be attributed to various factors.

4. Skin Changes: Skin changes like redness, scaling, or dimpling may occur, although these signs are more commonly associated with advanced breast cancers.

5. Nipple Abnormalities: Sometimes, the nipple might appear flattened, inverted, or change position. Nipple discharge, other than breast milk, can also be an indicator, but this is infrequent in DCIS cases.

 

Given DCIS's often subtle or absent symptoms, regular mammograms and routine breast health check-ups are vital for early detection and appropriate management.

 

What causes ductal carcinoma in situ?  

 

The exact cause of Ductal Carcinoma In Situ (DCIS) is not fully understood, but several factors

are thought to contribute:

 

1. Genetic Mutations: Alterations in specific genes, such as BRCA1 and BRCA2, can increase the risk of developing breast cancer, including DCIS. These mutations affect the cell's ability to repair DNA damage and regulate cell growth, potentially leading to abnormal cell growth in the breast ducts.

2. Hormone Receptor Status: Hormones like estrogen and progesterone can influence the growth of breast cells. DCIS cells are often hormone receptor-positive, which means they have receptors that respond to these hormones. Hormone imbalances or increased exposure to hormones over time can contribute to the development of DCIS.

3. Age and Gender: Advanced age and being female are significant risk factors for developing DCIS. As individuals age, accumulating genetic mutations and hormonal influences can increase the likelihood of abnormal cell growth.

4. Family History: A family history of cancer can raise the risk of DCIS. Inherited genetic mutations and shared environmental and lifestyle factors within families can contribute to this increased risk.

5. Radiation Exposure: Previous exposure to radiation therapy, particularly during chest radiation for treatment of another cancer at a young age, can elevate the risk of developing breast cancer, including DCIS, later in life.

 

How is ductal carcinoma in situ diagnosed? 

 

Diagnosing Ductal Carcinoma In Situ (DCIS) involves a series of steps to identify and characterize the condition accurately:

​

  1. Mammography: Routine screening mammograms are a primary tool for detecting DCIS, often before symptoms manifest. X-rays are used in mammograms to produce precise breast tissue images, allowing radiologists to identify abnormal calcifications or suspicious areas.

  2. Diagnostic Mammogram: A diagnostic mammogram is done if an abnormality is found on screening mammography. It involves more focused imaging to evaluate the specific area of concern better.

  3. Biopsy: A biopsy is performed to diagnose DCIS definitively. It involves removing a sample of the suspicious tissue for examination under a microscope. Types of biopsies include core needle biopsy, fine needle aspiration, or surgical biopsy.

  4. Pathology Analysis: A pathologist examines the biopsy tissue to determine whether abnormal cells are present within the breast ducts. The pathologist assesses the cells' characteristics, such as cell type, grade, and hormone receptor status, which inform treatment decisions.

  5. Imaging Tests: Additional imaging tests like ultrasound or MRI might be used to further assess the extent of the abnormal tissue and rule out the possibility of invasive cancer or multiple areas of DCIS.

 

What are the treatment options for ductal carcinoma in situ? 

 

Treatment options for DCIS depend on the individual case, and factors like the extent of the DCIS, patient preferences, and overall health are considered. Common treatment approaches followed by Dr Haytham El Salhat include the following:

​

  • Surgery - Lumpectomy: This procedure involves removing the DCIS and a small margin of healthy tissue around it. The breast is preserved as much as possible during a lumpectomy while the aberrant cells are entirely removed.

  • Surgery - Mastectomy: A mastectomy may be recommended in cases where the DCIS is extensive or recurring. It involves removing the entire breast tissue. Patients may opt for breast reconstruction following a mastectomy.

  • Radiation Therapy: After lumpectomy, radiation therapy is often recommended to target any remaining microscopic cancer cells in the breast. It reduces the risk of recurrence. Mastectomy patients might also receive radiation if the DCIS is high-grade or if other risk factors are present.

  • Hormonal Therapy: Hormone receptor-positive DCIS might be treated with hormonal therapy, such as tamoxifen or aromatase inhibitors. These medications reduce the influence of hormones on the growth of breast cells and lower the risk of recurrence.

  • Active Surveillance: In some low-risk cases, active surveillance, also known as watchful waiting, may be an option. Regular follow-up appointments, mammograms, and other imaging tests monitor any changes and initiate treatment if necessary.

 

What are the side effects of ductal carcinoma in situ treatments?

 

Depending on the specific treatment approach, treatment for DCIS can lead to various side effects. Some potential side effects include:

​

1. Surgery (Lumpectomy or Mastectomy):

  • Pain and discomfort at the surgical site

  • Swelling and bruising

  • Scarring

  • Temporary or permanent changes in breast appearance

  • Possible loss of sensation in the treated area

 

2. Radiation Therapy:

  • Irritation or redness 

  • Fatigue

  • Temporary changes in breast appearance, such as firmness or heaviness

  • Rare long-term effects on lung or heart function, particularly with left-breast radiation

 

3. Hormonal Therapy (Tamoxifen or Aromatase Inhibitors):

  • Hot flashes

  • Mood changes and depression

  • Joint pain and muscle aches

  • Vaginal dryness and decreased libido

  • High probability of blood clots or uterine cancer (for tamoxifen)

 

4. Side Effects Common to Multiple Treatments:

  • Anxiety and emotional distress related to diagnosis and treatment

  • Impacts on body image and self-esteem

  • Nausea or digestive issues (if undergoing chemotherapy in rare cases)

  • Hair loss (if undergoing chemotherapy in rare cases)

 

What is the prognosis for ductal carcinoma in situ? 

 

The prognosis for DCIS is generally favourable due to its non-invasive nature, but individual outcomes can vary based on several factors:

​

  • Early Detection: Regular screening improves outcomes by increasing the likelihood of successful treatment.

  • Treatment Success: Properly treated DCIS has a high survival rate, as it hasn't spread beyond the breast ducts.

  • Recurrence Risk: The risk of recurrence varies; higher-grade or larger DCIS lesions have a slightly increased risk.

  • Invasive Cancer Risk: Untreated or inadequately treated DCIS can progress to invasive breast cancer.

  • Long-Term Monitoring: Regular follow-up appointments, mammograms, and continued breast health care are essential to monitor for potential recurrence or new developments.

 

With timely and appropriate treatment, most individuals diagnosed with DCIS have a low mortality risk and an excellent long-term prognosis.

 

How can ductal carcinoma in situ be prevented? 

 

While there is no guaranteed way to prevent Ductal Carcinoma In Situ (DCIS), certain lifestyle choices and risk-reduction strategies may help lower the risk:

​

  • Regular Screening: Consistent mammograms and breast health check-ups enable early detection, increasing the chance of identifying DCIS at its earliest stage.

  • Healthy Lifestyle: Maintain a balanced diet of fruits, vegetables, whole grains, and lean proteins. Since obesity can lead to a higher risk of breast cancer, so it's important to exercise frequently and maintain a healthy weight.

  • Limit Hormone Therapy: If possible, avoid or limit hormone replacement therapy for menopause symptoms, as long-term use may increase the risk of certain breast cancers.

  • Breastfeeding: If feasible, breastfeeding your children might protect against breast cancer, including DCIS.

  • Know Your Family History: Understand your family's medical history, especially any instances of breast or ovarian cancer, as genetic factors can contribute to risk. 

 

What are the possible complications of ductal carcinoma in situ?

 

Complications associated with Ductal Carcinoma In Situ (DCIS) can arise after treatment:

​

  • Progression to Invasive Cancer: If left untreated or inadequately treated, DCIS can evolve into invasive breast cancer, where abnormal cells penetrate surrounding tissues. Regular monitoring and appropriate treatment are essential to prevent this progression.

  • Recurrence: Despite treatment, there is a potential for DCIS to recur. This risk is higher in cases with certain features, such as high-grade DCIS or positive surgical margins. Recurrence might necessitate further treatment.

  • Anxiety and Emotional Impact: A diagnosis of DCIS can cause significant emotional distress due to uncertainty about the condition's future course and the treatment decision-making process.

  • Treatment Side Effects: Surgical procedures can result in various side effects like pain, scarring, skin changes, and emotional challenges.

  • Impact on Quality of Life: Managing the physical and emotional aspects of DCIS and its treatment can affect a person's overall quality of life. Body image issues, anxiety, and changes in daily routines can lead to decreased well-being.

 

What are the patient resources for ductal carcinoma in situ?

 

There are various patient resources available for individuals diagnosed with DCIS to provide information, support, and guidance:

​

1. Breast Cancer Organizations:

  • American Cancer Society (ACS): Offers comprehensive information about DCIS, treatment options, and support services.

  • Susan G. Komen: Provides educational resources, treatment information, and support networks for breast cancer patients.

 

2. National Cancer Institutes:

  • National Cancer Institute (NCI): Offers up-to-date information on DCIS research, treatment guidelines, and clinical trials.

 

3. Online Communities and Forums:

  • Breast cancer forums and online support groups, like Breastcancer.org and Inspire, allow patients to relate with other patients facing similar challenges, share experiences, and ask questions.

 

4. Cancer Treatment Centers:

  • Reputable cancer treatment centres often provide dedicated sections on their websites for patient education and resources related to breast cancer, including DCIS.

 

5. Local Support Groups:

  • Local cancer centres or community organizations may host in-person or virtual support groups where patients can share experiences, receive emotional support, and access valuable resources.

 

What are the most common types of ductal carcinoma in situ? 

 

The most common types of Ductal Carcinoma In Situ (DCIS) are differentiated based on their cellular characteristics:

​

  • Comedo DCIS: This type features large, central necrosis (cell death) areas that appear chalky white or yellowish. Comedo DCIS is often associated with higher-grade tumours and a slightly increased risk of recurrence.

  • Papillary DCIS: Characterized by finger-like projections within the breast ducts, resembling the structure of a papilloma. While generally low-grade, papillary DCIS can still require treatment due to the risk of progression.

  • Cribriform DCIS: Exhibits a Swiss cheese-like pattern of small, rounded spaces surrounded by tumour cells. It's usually low-grade and associated with a favourable prognosis.

  • Solid DCIS: In this type, cells fill the ducts without forming specific patterns. Solid DCIS may have variable grades and behaviour, making treatment decisions more individualized.

  • Micropapillary DCIS: Similar to papillary DCIS, but with smaller projections. It's often high grade and might have an increased likelihood of recurrence.

bottom of page